Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2404 participants
INTERVENTIONAL
2021-06-30
2022-01-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reminder Modality for CRC Screening
NCT05012007
Improving Fecal Occult Blood Test Completion Rates Among Veterans
NCT01516489
Implementing Fit Kit Colorectal Cancer (CRC) Screening in High Risk Populations
NCT04848051
The PRIME-CRC Trial to Promote CRC Screening in Rural Communities
NCT04313114
Promoting Veteran-Centered Colorectal Cancer Screening
NCT02027545
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Active arm: Primer
1. Intervention Type: Other
2. Intervention Description: Mailed postcard notifying Veteran of upcoming FIT kit receipt for annual CRC screening
2. Control arm: No primer a. Intervention Type: No intervention
Randomization will be stratified within arms by prior screening status (prior screener vs. never screener)
Our primary outcome of interest is the return rate at three months post randomization. Our secondary outcome of interest is the return rate at six months post randomization. Enrollment in the trial will occur between May 1, 2021 and January 1, 2022.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active
Primer
Primer
Mailed postcard notifying Veteran of upcoming FIT kit for annual CRC screening.
Control
No Primer
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Primer
Mailed postcard notifying Veteran of upcoming FIT kit for annual CRC screening.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Assigned to a primary care provider at the VA Puget Sound as of January 1, 2021
* At least 1 year of prior data available (evidence of at least one outpatient visit)
* Due for annual colorectal (CRC) screening
Exclusion Criteria
* Not currently receiving hospice care
* No record of recent death in the administrative data.
* No history of CRC or history of prior colectomy.
50 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Puget Sound Health Care System
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alaina Mori
Staff Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ashok Reddy, MD
Role: PRINCIPAL_INVESTIGATOR
VA Puget Sound Health Care System
Stefanie Deeds, MD
Role: PRINCIPAL_INVESTIGATOR
VA Puget Sound Health Care System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Puget Sound Health Care System
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FIT1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.